CNX Therapeutics | B Corp™ Certified

CNX Therapeutics | B Corp™ Certified is a leading European pharmaceutical company committed to enhancing patient well-being through the provision of essential medicines. With a focus on commercial excellence and patient-centric solutions, CNX Therapeutics operates across more than 60 countries worldwide, establishing itself as a trusted partner within the healthcare sector.

Strategically licensing and distributing a comprehensive portfolio of medicines for CNS, critical care, and various other conditions, CNX Therapeutics leverages both direct channels and strategic alliances to ensure widespread access to vital treatments. As a certified B Corp company, CNX Therapeutics adheres to the highest standards of social and environmental performance, demonstrating a deep commitment to building a healthier world.

Located at LABS House, 15-19 Bloomsbury Way, London, WC1A 2TH, GB, CNX Therapeutics is poised for continued growth and innovation within the pharmaceutical industry. We invite the management team at CNX Therapeutics | B Corp™ Certified to further enrich this profile with a customized and exclusive company showcase and product listing on our platform.